• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Zentek Announces Preliminary Battery Results and University of Toronto Receives NSERC Mission Alliance Grant to Optimize Graphite for Battery Anode Use

    8/8/24 7:07:00 AM ET
    $ZTEK
    Major Chemicals
    Industrials
    Get the next $ZTEK alert in real time by email

    GUELPH, ON / ACCESSWIRE / August 8, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company is pleased to announce preliminary battery results and the commencement of a three-year, $441,000 project in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto ("U of T"). Funding for the project is provided by a Natural Sciences and Engineering Research Council of Canada ("NSERC") Mission Alliance Grant. Prof. Sain is the Endowed Ford Motor Canada Chair in Sustainable Materials and Prof. Yan is the Tier 1 Canada Research Chair in Sustainable Bioproducts.

    Highlights

    • Three-year $441,000 funding to optimize graphite for anode material.

    • Promising preliminary results have already been achieved from this research with pouch cell batteries featuring engineered Albany graphite by U of T with a minimum 17% increase in capacity over batteries using commercial grade anode material.

    • The project complements the $1.6M Mitacs research project with the same group, announced on October 28, 2022, aimed at inventing multifunctional materials for automotive batteries including anode, cathode, separator and electrolyte chemistries.

    Graphite is one of the six minerals identified by the Canadian government as a priority on its list of critical minerals, with electric vehicle batteries requiring up to 125 kg of graphite per vehicle. Unlike most critical minerals, graphite's value varies widely based on use cases, which require different purity, crystallinity, shape and flake size thresholds.

    With significant investment in the North American battery supply chain and growing demand for finished anode material, the company is exploring both graphite production from its Albany Deposit and graphite processing to produce battery-ready anode material.1 The U of T project will play a significant role in this strategy.

    The project with Profs. Sain and Yan will characterize and optimize the Albany Graphite by exploring various pathways to purify, increase capacity, enhance cycle life, and engineer the graphite to meet or exceed commercial standards for anode material in the EV market.

    The U of T team brings experience from producing battery technology for the Ford Powertrain Engineering Research and Development Centre ("PERDC") and has recently expanded battery production capabilities at U of T to accomplish all critical processes and tests.

    The U of T team has already successfully increased the capacity of an engineered graphite anode material through a simple modification step, resulting in pouch cell batteries with initial results showing a 17% increased capacity over pouch cell batteries using commercial-grade anode materials. These results are preliminary and will be verified through further testing or at an independent third-party facility. Improvements have also been achieved in other performance metrics which will be announced in subsequent updates.

    Greg Fenton, Zentek CEO commented, "We are very pleased to see our collaboration expand with Profs. Sain and Yan, who are some of Canada's leading experts in carbon technology. We are confident that their experience and innovation will be instrumental in achieving our goal of developing premium anode materials which can be translated to graphite from the Albany deposit resulting in a finished product that outperforms commercial anodes in energy capacity, cycle life, and charging rate. The potential of our Albany Graphite continues to grow. We have received positive feedback from government and industry regarding our ability to upgrade Albany Graphite to achieve five nines purity. Integrating that purity with the graphite engineering work from Prof. Sain's team will lead to greater value as we pursue the value-add processing component of the anode supply chain to create a vertically integrated anode solution."

    About Zentek Ltd.

    Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the company's commercial partners a competitive advantage by making their products better, safer, and greener.

    Zentek's patented technology platform ZenGUARD™, is demonstrated to have 99-per-cent anti-microbial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario. Zentek's patent pending ZenARMOR™ technology platform is focused on corrosion protection applications.

    Zentek has a global exclusive license to the Aptamer-based platform technology developed by McMaster University which is being jointly developed Zentek and McMaster for both the diagnostic and therapeutic markets.

    For further information:

    [email protected]

    Ryan Shacklock
    Tel: (306) 270-9610
    Email: [email protected]

    To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR profile at http://www.sedar.com/.

    Forward-Looking Statements

    This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

    Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    SOURCE: Zentek Ltd.



    View the original press release on accesswire.com

    Get the next $ZTEK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ZTEK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZTEK
    Leadership Updates

    Live Leadership Updates

    See more
    • Zentek Reports Improvements and Expansion of its Aptamer-Based Platform Technology

      GUELPH, ON / ACCESSWIRE / November 15, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company announces the development of a significant upgrade to its aptamer platform improving the binding affinity of the universal Covid-19 aptamer from 300 to over 500 times, compared to the base aptamer. The improved platform has also solved key challenges for manufacturing and these High-Binding Affinity (HBA) aptamers are now produced with approximately a 95% yield. A key roadblock of translating a promising lead candidate (lab-scale therapeutic) into a commercial product is cost-effective and high-purity manu

      11/15/23 8:15:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • Zentek Announces the Launch of Subsidiary for Aptamer-Based Platform Technology

      GUELPH, ON / ACCESSWIRE / October 5, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company announces the launch of a wholly-owned subsidiary that will own the exclusive, global licensing rights for all aptamer-based technology from the collaboration with McMaster University. This licensing agreement includes the rapid-detection platform and the recent aptamer-based platform technology developed by Dr. Yingfu Li and his team that is showing promise as a therapeutic through preclinical studies being conducted by Dr. Matthew Miller and his team. This new entity has been launched as a vehicle to accel

      10/5/23 7:15:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • Zentek Announces Appointment of New Director of Investor Relations

      GUELPH, ON / ACCESSWIRE / January 12, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK);(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Mr. Mitch Swergold as its Director of Investor Relations.Mr. Swergold earned a Bachelor of Arts in Political Science from Columbia University in the City of New York, and a Juris Doctor degree from Emory University School of Law. After practicing law and serving as a research analyst at two investment banks, Mr. Swergold was a Senior Analyst and Portfolio Manager at various hedge funds, focusing on technology and macroeconomic investing."Mitch's experience investing in technology companies, from early to la

      1/12/23 8:00:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials

    $ZTEK
    SEC Filings

    See more
    • SEC Form 6-K filed by Zentek Ltd.

      6-K - Zentek Ltd. (0001904501) (Filer)

      5/16/25 9:50:10 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • SEC Form 6-K filed by Zentek Ltd.

      6-K - Zentek Ltd. (0001904501) (Filer)

      4/23/25 10:18:41 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • SEC Form 6-K filed by Zentek Ltd.

      6-K - Zentek Ltd. (0001904501) (Filer)

      4/17/25 4:35:03 PM ET
      $ZTEK
      Major Chemicals
      Industrials

    $ZTEK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Zentek Provides Update on ZenGUARD(TM) Enhanced Air Filters for the Canadian Market

      GUELPH, ON / ACCESS Newswire / January 17, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on the launch of ZenGUARD™ Enhanced Air Filters in the Canadian Market.The Company is prioritizing the completion of all required documentation to support the manufacture and sale of ZenGUARD™ Enhanced Air Filters under its existing medical device establishment licence ("MDEL") alongside ZenGUARD™ Surgical Masks. This documentation will be completed in compliance with Canadian Medical Device Regulations (MDR) and ISO 13485:2016 Quality Management System for medical devices.The Com

      1/17/25 8:00:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • Zentek Subsidiary Albany Graphite Corp. Simplifies Process to Achieve Five Nines Purity

      GUELPH, ON / ACCESSWIRE / January 8, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company is pleased to announce that its wholly owned subsidiary, Albany Graphite Corporation (AGC) has achieved a preliminary five-nines purity of 99.9991% directly from a larger Albany graphite deposit flotation concentrate sample utilizing an operational pilot-scale fluidized bed reactor (FBR).HighlightsUltra-high purity "five nines" 99.9991 wt.% from a platinum crucible Loss on Ignition (LOI) analysisPurification was performed utilizing an existing pilot-scale FBR directly on a ~950 g sample of the Albany flotati

      1/8/25 9:10:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials
    • Zentek Provides Update on International Opportunities

      GUELPH, ON / ACCESSWIRE / December 12, 2024 / Zentek Ltd. (" Zentek "or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has signed a Memorandum of Understanding ("MOU") with Al-Ramez International Group - through Saudi Excellence Holding Company - establishing a strategic partnership to drive innovation and commercialization in advanced technologies across the Kingdom of Saudi Arabia ("KSA") and the Middle East and North Africa ("MENA") region on November 14 th 2024.Memorandum of Understanding OverviewThe MOU outlines a collaborative framework where Zentek intends to contribute intellectual property, product licensing, and researc

      12/12/24 8:30:00 AM ET
      $ZTEK
      Major Chemicals
      Industrials